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Abstract
Background: Autism is a complex, heterogeneous, behaviorally-defined disorder characterized by disruptions of the
nervous system and of other systems such as the pituitary-hypothalamic axis. In a previous genome wide screen, we
reported linkage of autism with a 1.2 Megabase interval on chromosome 5q31. For the current study, we hypothesized
that 3 of the genes in this region could be involved in the development of autism: 1) paired-like homeodomain
transcription factor 1 (PITX1), which is a key regulator of hormones within the pituitary-hypothalamic axis, 2) neurogenin
1, a transcription factor involved in neurogenesis, and 3) histone family member Y (H2AFY), which is involved in X-
chromosome inactivation in females and could explain the 4:1 male:female gender distortion present in autism.
Methods: A total of 276 families from the Autism Genetic Resource Exchange (AGRE) repository composed of 1086
individuals including 530 affected children were included in the study. Single nucleotide polymorphisms tagging the three
candidate genes were genotyped on the initial linkage sample of 116 families. A second step of analysis was performed
using tightly linked SNPs covering the PITX1 gene. Association was evaluated using the FBAT software version 1.7.3 for
single SNP analysis and the HBAT command from the same package for haplotype analysis respectively.
Results: Association between SNPs and autism was only detected for PITX1. Haplotype analysis within PITX1 showed
evidence for overtransmission of the A-C haplotype of markers rs11959298 – rs6596189 (p = 0.0004). Individuals
homozygous or heterozygous for the A-C haplotype risk allele were 2.54 and 1.59 fold more likely to be autistic than
individuals who were not carrying the allele, respectively.
Conclusion: Strong and consistent association was observed between a 2 SNPs within PITX1 and autism. Our data
suggest that PITX1, a key regulator of hormones within the pituitary-hypothalamic axis, may be implicated in the etiology
of autism.
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Background
Autism spectrum disorder is a complex, heterogeneous,
behaviorally-defined disorder with a 4:1 male:female gen-
der distortion [1]. Although environmental elements,
such as peri- and post-natal stress, have been reported to
contribute to the development of autism, monozygotic
twin studies along with evidence of chromosomal abnor-
malities, mutations in single genes, and multiple gene
polymorphisms in autistic individuals, clearly show that
autism is a largely genetic disorder [2-5].
Single mutations in neuroligin 3 and 4, cell adhesion mol-
ecules present at the post-synaptic side of the synapse, and
in SHANK3, a scaffolding protein found in excitatory syn-
apses, have been described in autistic individuals [6,7]. In
the majority of cases, however, an overall lack of Mende-
lian inheritance suggests the involvement of multiple
genes [5,8]. Indeed, genome-wide screens and candidate
gene approaches have identified a number of chromo-
somal regions and genes linked with autism [9-19]. For
example, a strong association between autism and
SLC25A12, a gene encoding the mitochondrial aspartate/
glutamate carrier AGC1 expressed in neurons and in neu-
ral stem cells, has been reported in 2 separate studies
[17,19]. Similarly, an analysis of chromosome 16p
revealed an association between autism and the protein
kinase c-beta gene (PRKCB1), which is expressed in gran-
ule cells of the brain and B lymphocytes [20].
Although most of the genetic analyses, to date, have
focused on genes expressed in the brain, the pathophysi-
ology of autism suggests that other systems such as the
immune system and the pituitary-hypothalamic axis may
be involved [21,22]. In some autistic individuals, for
example, abnormal secretion of pro-opio-melanocortin
(POMC), adrenocorticotropin (ACTH), cortisol, and beta-
endorphin has been noted [22-25].
We recently performed a genome-wide linkage scan in a
group of families with autism and phrase speech delay
identified in the Autism Genetic Resource Exchange
(AGRE) DNA repository [20]. Among the 7 genomic
regions that showed a significant increase in identity-by-
descent sharing in sibling pairs with autism, 4 corre-
sponded to regions that have previously been linked to
autism (chromosome 5, 13, 16, and 17) [20]. Based on
these results, in the current study, we focused on chromo-
some 5q31 and identified 3 genes that we hypothesized
could be involved in the development of autism: 1)
paired-like homeodomain transcription factor 1 (PITX1),
which is a key regulator of hormones within the pituitary-
hypothalamic axis such as ACTH, cortisol, and beta-
endorphin [22,26,27]; 2) histone family member H2AFY,
which is involved in X-inactivation in females and there-
fore could be a positional candidate that could explain the
4:1 male:female gender distortion present in autism
[1,28]; and 3) Neurogenin 1 (NEUROG1), which is a tran-
scription factor involved in neurogenesis [29]. Using sin-
gle point association analyses and haplotype analyses, we
found significant evidence for an association of autism
with PITX1 but not with H2AFY or NEUROG1.
Methods
Subjects
Two-hundred and seventy-six families were selected from
the AGRE program composed of 1086 individuals includ-
ing 530 affected children. AGRE has been approved by an
Institutional Review Board (IRB) to ensure the protection
of research participants [30]. Each family had at least two
affected children. No un-affected children were included
in the study. In each family, affected siblings met the diag-
nostic criteria for autism according to the Autism Diag-
nostic Interview Revised (ADI-R) [31]. No families with
known genetic defects like fragile X, RETT syndrome, or
other monogenic forms of autism were included. Written
informed consent was obtained from all parents included
in the study. One-hundred sixteen families initially used
in the linkage study were included in this study [20]. In
these families, the Autism Diagnostic Observation Sched-
ule (ADOS) evaluation was performed in 48% of the
affected individuals and the concordance rate between
ADI-R and ADOS was 94%.
Candidate gene, SNP selection, and genotyping
Genes were annotated according to the 35th version of the
NCBI database [32]. In a first step, the three candidate
genes were genotyped using on the same sample of 116
families as for the linkage study. A second step of analysis
was performed using tightly linked SNPs covering gene(s)
showing suggestive association at a nominal level in the
first step. SNPs were genotyped according to the manufac-
turer's recommendations using oligoligation assays,
(SNPlex) or TaqMan (Applied Biosystems, Foster City)
Statistical analysis
The SNPs pairwise LD was evaluated by the measures of D'
using the LDheatmap package. Hardy-Weinberg equilib-
rium (HWE) was tested in parents using the exact Chi-
square statistic test [33].
Single SNP and haplotype association tests were carried
out using FBAT version 1.7.3 [34]. Haplotype-specific
association were also tested using the HBAT option in the
FBAT package. Both single and haplotype analysis were
performed using the empirical variance option to account
for the linkage in the region studied. Nominal P-values
were provided for each haplotype with more than ten
informative families. First step analyses were not corrected
for multiple testing since it was performed under a strong
candidate gene hypothesis to identify potential associa-BMC Medical Genetics 2007, 8:74 http://www.biomedcentral.com/1471-2350/8/74
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tion with the disease at the nominal level. However, p-val-
ues were corrected for multiple testing in the second step.
Multiple hypothesis testing was controlled using the false
discovery rate (FDR) approach proposed by Benjamini
and Hochberg [35]. Because of the non-independence of
tests, this method is conservative (but less so than the
Bonferroni correction) and generally tends to underesti-
mate statistical significance.
To estimate relative risk (RR) of marker(s) identified as
associated to autism in the present paper, we used a con-
ditional likelihood based method [36]. This method esti-
mates haplotype RRs under an additive model from
unphased data but also single marker like SNP risk and
provides unbiased RR in case of deviation from HWE.
Results
Gene specific single point association analysis
Of the 16 known genes in the 1.2 Mb region of chromo-
some 5q31 (Table 1), which was identified in a previous
genome-wide linkage analysis for autism [20], 3 were
selected as candidate genes based on function:
PITX1,H2AFY, and NEUROG1 (Figure 1).
A two step procedure was used to screen the candidate
genes for association with autism. The average genotyping
success rate was > 92%. All markers, except rs474853 were
in Hardy-Weinberg equilibrium (Table 2). One family
was removed from the analysis because of Mendelian
incompatibilities.
Single marker analysis revealed nominally significant p-
values for 3 of the 5 SNP markers selected for PITX1:
rs28330 (p  = 0.013), rs3805663 (p  = 0.0061), and
rs1700488 (p = 0.0191) (Table 2). Marker rs1700488 is
positioned 4.4 kb upstream of the first exon of PITX1.
Marker rs28330 is located 11 kb 3' from the last exon of
PITX1. Marker rs3805663 lies between exon 3 and 4 of
PITX1. Mutation screening by direct sequencing did not
show any amino-acid or other mutational changes (data
not shown).
To further investigate PITX1 9 SNPs, including new mark-
ers not genotyped in phase 1, were selected to fully cap-
ture the polymorphic information of the gene and
genotyped in an extended family set of 276 AGRE fami-
lies. Two markers showed strong significant evidence for
association (rs11959298, p = 2 * 10-4 and rs6596189, p =
1 * 10-4) and 3 other markers (rs1131611, rs6872664,
rs6596188) reached significance even after correcting for
multiple testing (Table 3).
Linkage disequilibrium and haplotype analysis of PITX1 
gene
Haplotypes analysis was conducted to extract more inher-
itance information from the set of markers. As a first step,
the LD structure among the 9 markers was evaluated in
PITX1 (Figure 2). We observed two blocks of LD, a four
SNP block (block 1) and a two SNPs block (block 2).
Block 1 is composed of SNPs that individually were not
significant after correction for multiple testing. Grouping
into haplotypes, did not increase significance after correc-
tion, apart from a slight tendency for a protective effect of
haplotype C-T-A-G (Table 4). The second LD block con-
tains two SNPs that showed significant association with p
= 0.0084 (pcorrected = 0.0178) for the two haplotype alleles
having a frequency greater than 0.05). This block is bor-
dered by two SNPs (rs11959298 and rs6596189) that
Table 1: Genes identified in a 1.2 Mb linkage region of chromosome 5q31
Name Product NCBI GENE ID. OMIM ID.
DDX46 DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 9879 NULL
Corf14 Disulfide isomerase 79770 NULL
PCBD2 Dimerization cofactor of hepatocyte nuclear 84105 NULL
CATSPER3 Cation channel, sperm associated 3 347732 609120
PITX1 Paired-like homeodomain transcription factor 1 5307 602149
H2AFY H2A histone family, member Y isoform 9555 NULL
DCNP1 Dendritic cell nuclear protein 1 140947 NULL
TIFAB TIFA related protein 497189 NULL
NEUROG1 Neurogenin 1 4762 601726
CXCL14 Small inducible cytokine B14 precursor 9547 604186
IL9 Interleukin 9 precursor 3578 146931
FBXL21 F-box and leucine-rich repeat protein 21 26223 609087
LECT2 Leukocyte cell-derived chemotaxin 2 3950 602882
TGFβ1 Transforming growth factor, beta-induced 7045 601692
SMAD5 SMAD, mothers against DPP homolog 5 4090 603110
TRPC7 Putative capacitative calcium channel 57113 NULLBMC Medical Genetics 2007, 8:74 http://www.biomedcentral.com/1471-2350/8/74
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present strong LD (D' = 1.0 and r2 = 0.98) between them
and milder LD (D' = 0.83 or 0.85) with markers from
block 2 (Figure 2). They displayed the strongest significant
single point association and combined into haplotypes
also provided strong evidence for association with p =
0.0004 (pcorrected = 0.0017) for haplotype A-C (Z-score =
3.530). Defining allele A-C as the risk allele and
homozygous carrier of allele G-T as the reference geno-
type, we estimated the RR to 1.59 ([1.26 ; 2.02] 95% con-
fidence interval) for a heterozygous carrier and 2.54
([1.58 ; 4.09]) for homozygous carrier.
Discussion
In this study, we have found a significant association
between autism and polymorphisms of PITX1, a paired-
like homeodomain transcription factor involved in hor-
monal regulation [26,27]. Using a two step procedure we
initially identified evidence for association for marker
rs3805663 with autism. In the second step additional
markers in the PITX1 gene were genotyped in an extended
sample set of 276 families total. Although in this extended
set marker rs3805663 did not reach a significant p-value
any more, several additional markers showed highly sig-
nificant results with the most significant result for
rs6596189 (p = 1 * 10-4). Haplotype analyses yielded a
Genomic organization of the linkage region on chromosome 5q31 and haplotype heat-map of PITX1 Figure 1
Genomic organization of the linkage region on chromosome 5q31 and haplotype heat-map of PITX1. A) Five 
clones in the region showed elevated identity-by-descent sharing values. The highest p-value was observed for clone 
FE0DBACA4ZA08 (p = 6.40 * 10-7, position (built 34) = chr5:134.467.793 – 134.639.841). Orientation of gene transcription is 
indicated by arrows. The bottom panel shows the exon-intron structure of the PITX1 gene. Two transcripts have been 
described for the gene, which make use of the same start and stop codons but differ in their respective 5' and 3' UTR regions.BMC Medical Genetics 2007, 8:74 http://www.biomedcentral.com/1471-2350/8/74
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Table 2: Association analyses with tag-SNPs selected in candidate genes. Single point SNP analysis results of first step analysis of 
PITX1, H2AFY, and NEUROG1 in 116 families from the initial linkage scan. Base positions are indicated according to built 35 of the 
human genome sequence. MAF, minor allele frequency; perm, permutations; SNP, single nucleotide polymorphism; HWE, Hardy-
Weinberg equilibrium probability test. Association analysis was performed using the FBAT package.
SNP Position (b35) MAF (Allele) HWE Z-score (Allele) P-value
PITX1 rs28330 134,380,433 0.37 (T) 0.65 2.483 (C) 0.0130
rs31210 134,388,918 0.21 (A) 1.00 1.136 (G) 0.2560
rs474853 134,392,990 0.47 (T) <10-5 0.62 (C) 0.5351
rs3805663 134,394,099 0.31 (G) 1.00 2.741(A) 0.0061
rs1700488 134,402,776 0.08 (A) 1.00 2.343 (G) 0.0191
H2AFY rs13163460 134,692,981 0.21 (T) 0.52 1.084 (G) 0.2784
rs6865399 134,702,478 0.10 (G) 1.00 1.294 (G) 0.1957
rs2292011 134,707,146 0.22 (T) 0.85 1.453 (C) 0.1462
rs1393082 134,734,972 0.39 (A) 0.89 2.004 (C) 0.0450
rs3776203 134,736,664 0.15 (T) 0.79 1.065 (C) 0.2869
NEUROG1 rs6596238 134,892,355 0.39 (A) 0.55 0.769 (A) 0.4419
rs245128 134,908,890 0.35 (A) 0.33 1.044 (G) 0.2963
Table 3: Extended SNP analysis in the PITX1 gene. In the second step additional markers were added in the PITX1 gene analysis. Also 
160 further families were added to the analysis of PITX1in this step. Thus step 2 included a total of 276 families for genotyping. Markers 
rs28330, rs31210, rs474853, rs3805663, rs1700488, rs13163460, rs3776203, rs6596238, rs245128, rs2249596, rs1131611, rs254550, and 
rs254551 were genotyped using SNPlex. Markers rs6865399, rs2292011, rs1393082, rs657223, rs7700313, and rs39882 were genotyped 
using TaqMan, respectively. Base positions are indicated according to built 35 of the human genome sequence. MAF, minor allele 
frequency; perm, permutations; SNP, single nucleotide polymorphism; HWE, Hardy-Weinberg equilibrium probability test. 
Association analysis was performed using the FBAT package.
SNP Position (built 35) MAF (Allele) HWE Z-score (Allele) P-value (Pcorrected)
rs657223 134,383,698 0.40(T) 0.21 1.287(A) 0.1980
rs479632 134,392,417 0.23 (G) 1.00 0.539 (C) 0.5896
rs1131611 134,392,894 0.12 (T) 0.41 2.433 (G) 0.0150 (0.0283)
rs888685 134,393,688 0.36 (A) 0.40 1.929 (T) 0.0537
rs3805663 134,394,099 0.36 (G) 0.22 1.425 (A) 0.1542
rs11959298 134,395,438 0.13 (G) 1.00 3.668 (A) 0.0002 (0.0017)
rs6872664 134,395,496 0.12 (T) 0.31 2.814 (C) 0.0049 (0.0167)
rs6596188 134,396,001 0.12 (T) 0.31 2.636 (A) 0.0084 (0.0178)
rs6596189 134,396,067 0.13 (T) 0.70 3.825 (C) 0.0001 (0.0017)
rs7700313 134,396,298 0.12 (T) 0.82 1.897 (T) 0.0578
Table 4: Results of haplotype association analysis
SNPs ID Alleles Freq. Z-score P-value3 (Pcorrected) Relative Risk
rs479632 – rs1131611 – rs888685 – rs3805663 C-G-T-A 0.64 2.000 0.0455 (0.0703)
G-G-A-G 0.24 -0.267 0.7894
C-T-A-G 0.11 -2.249 0.0245 (0.0416)
rs6872664 – rs6596188 C-A 0.88 2.636 0.0084 (0.0178)R R HT = 1.46 [1.13; 1.88]
RRHO = 2.12 [1.27; 3.54]
T-T 0.12 -2.636 0.0084 (0.0178)
rs11959298 – rs6596189  A-C 0.88 3.530 0.0004 (0.0017)R R HT = 1.59 [1.26; 2.02]
RRHO = 2.54 [1.58; 4.09]
G-T 0.12 -3.630 0.0003 (0.0017)BMC Medical Genetics 2007, 8:74 http://www.biomedcentral.com/1471-2350/8/74
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couple of highly significant pairings, although none of
these showed higher significance than rs6596189 alone.
Individuals homozygous or heterozygous for the risk
allele were 2.69 and 1.74 fold more likely to be autistic
than individuals who were not carrying the allele, respec-
tively.
PITX1 is a key regulator of hormonal genes in the pitui-
tary-hypothalamic axis. Its putative involvement in
autism is supported by evidence documenting abnormal
levels of hormones such as ACTH, beta-endorphin, and
cortisol in autistic individuals and by the fact that these
hormones are downstream of PITX1 [22-27]. Deregula-
tion of POMC and high levels of beta-endorphin in the
morning, for example, have been shown to be involved in
certain maladaptive behaviors, such as self-injurious
behaviors, which are often seen in autistic individuals
[37]. The ACTH-cortisol system, which also plays an
important role in stress related responses, is impaired in
autistic individuals in whom lower cortisol levels and
higher ACTH levels have been reported [24].
Linkage between chromosome 5q31-32 and autism is
consistent with previously published studies. Both the
IMGSAC (1998) genome-wide linkage scan and the
screen performed by Risch and colleagues found modestly
elevated LOD-scores in this region and exclusion map-
ping analyses did not clearly exclude this region [10,12].
Interestingly, this genomic region was recently identified
as a potential locus for attention deficit/hyperactivity dis-
order (ADHD) [38-40]. In a genome-wide scan using large
Linkage disequilibrium (LD) map of the PITX1.gene Figure 2
Linkage disequilibrium (LD) map of the PITX1.gene. Thirteen SNP markers within the 6.5 kb of genomic sequence span 
the 5' and 3' UTRs of PITX1. Pair-wise LD among SNPs was investigated using D'. Haplotype blocks were determined by iden-
tifying the first and last markers in a block, which are in strong LD with all intermediate markers. The structure and position of 
the PITX1 gene, the positions of the 5 SNPs from the first step genotyping and the 9 SNPS from the second step genotyping are 
indicated (SNP markers in bold), respectively. LD, linkage disequilibrium; SNP, small nucleotide polymorphism; UTR, 5'-
untranslated regions.BMC Medical Genetics 2007, 8:74 http://www.biomedcentral.com/1471-2350/8/74
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multi-generational pedigrees, Arcos-Burgos and col-
leagues established an exclusion map for the region and
defined a critical interval from 119 to 135 Mb, which
encompasses the PITX1 gene region [38]. Their most sig-
nificant family-specific microsatellite marker D5S2117 at
133.4 Mb is less than 1 Mb from the PITX1 gene locus.
Mutation screening of the coding region of PITX1 revealed
a single known mis-sense mutation with a MAF of 0.33. As
the single point association results did not show any evi-
dence for association, the mutation seems unlikely to be
directly involved in susceptibility to autism. The most
positive SNPs in the single marker analysis as well as the
positive haplotypes are all situated in the first intron of
the PITX1 gene. Regulatory site analysis shows a predic-
tion for an alternative promoter at bases 134394831–
134395400, which overlaps exactly with the region cov-
ered by the four most significant SNPs. However, to our
knowledge activity of this predicted promoter has not
been shown. Also these SNPs are in strong LD with SNPs
within the 5' region of the PITX1 gene and the designated
promoter region. However, one SNP within the PITX1
promoter, rs7700313 genotyped by us did not show sig-
nificant evidence for association (pnominal = 0.0578, Table
3). Therefore at this stage it is not possible to postulate
where the functional variant is situated and if any of the
SNPs genotyped is functional.
The linkage region also covers the H2AFY and NEUROG1
loci, which in view of their function in X-chromosome
inactivation and neuronal development, respectively,
were considered reasonable candidates [28,29,40,41]. We
found associations neither for the 5 SNPs selected for
H2AFY nor for the 2 SNPs selected for NEUROG1. More-
over, mutation screening by direct sequencing did not
show any amino-acid or other mutational changes within
these genes.
Conclusion
Although the mechanisms by which PITX1 may contrib-
ute to the susceptibility to autism are yet to be explored,
the genetic association between PITX1  polymorphisms
and autism, described here, could provide an explanation
for the abnormal level of hormones of the pituitary-adre-
nal axis reported in the literature.
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